Comparison of the pharmacokinetics and clinical efficacy of new extended-release formulations of methylphenidate

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.9, Iss.8, 2013-08, pp. : 1001-1014

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Comparison of the Pharmacokinetics of Methylphenidate Extended‐Release Orally Disintegrating Tablets With a Reference Extended‐Release Formulation of Methylphenidate in Healthy Adults

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 2, 2018-02 ,pp. : 151-159

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of Antacid on the Pharmacokinetics of Extended-Release Formulations of Tolterodine and Oxybutynin

By Gayatri Sathyan

Clinical Pharmacokinetics, Vol. 43, Iss. 14, 2004-01 ,pp. : 1059-1068

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Ritalin ® LA, a New, Once Daily, Extended-Release Dosage Form of Methylphenidate, in Children with Attention Deficit Hyperactivity Disorder

By Biederman J.

Pediatric Drugs, Vol. 5, Iss. 12, 2003-01 ,pp. : 833-841

Adis International

Access to resources Recommend Favorite

Extended Release Formulations of Anticonvulsant Medications: Clinical Pharmacokinetics and Therapeutic Advantages

By Collins R.J. Garnett W.R.

CNS Drugs, Vol. 14, Iss. 3, 2000-09 ,pp. : 203-212

Adis International

Access to resources Recommend Favorite

Extended-Release Methylphenidate (Ritalin LA)

By Lyseng-Williamson K.A. Keating G.M.

Drugs, Vol. 62, Iss. 15, 2002-01 ,pp. : 2251-2259

Adis International

Access to resources Recommend Favorite